297 related articles for article (PubMed ID: 10695615)
21. No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori.
Tan AC; den Hartog G; Meijer JW; Thies JE; de Vries RA; Mulder CJ
Helicobacter; 1997 Dec; 2(4):194-8. PubMed ID: 9421123
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
[TBL] [Abstract][Full Text] [Related]
23. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
24. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic options after failed Helicobacter pylori eradication therapy.
van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
[TBL] [Abstract][Full Text] [Related]
27. Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Dubois A; Berg DE; Fiala N; Heman-Ackah LM; Perez-Perez GI; Blaser MJ
J Gastroenterol; 1998 Feb; 33(1):18-22. PubMed ID: 9497216
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
29. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Kato S; Takeyama J; Ebina K; Naganuma H
Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
[TBL] [Abstract][Full Text] [Related]
30. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Pilotto A; Perri F; Leandro G; Franceschi M;
Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
[TBL] [Abstract][Full Text] [Related]
31. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
32. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
34. A short-term eradication therapy for Helicobacter pylori acute gastritis.
Nomura H; Miyake K; Kashiwagi S; Sugiyama T; Asaka M
J Gastroenterol Hepatol; 2000 Dec; 15(12):1377-81. PubMed ID: 11197046
[TBL] [Abstract][Full Text] [Related]
35. Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
Cadranel S; Bontemps P; Van Biervliet S; Alliet P; Lauvau D; Vandenhoven G; Vandenplas Y
Acta Paediatr; 2007 Jan; 96(1):82-6. PubMed ID: 17187610
[TBL] [Abstract][Full Text] [Related]
36. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression.
Moayyedi P; Wason C; Peacock R; Walan A; Bardhan K; Axon AT; Dixon MF
Helicobacter; 2000 Dec; 5(4):206-14. PubMed ID: 11179985
[TBL] [Abstract][Full Text] [Related]
37. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Talley NJ; Vakil N; Ballard ED; Fennerty MB
N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
39. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]